Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 20, 2018 11:45 ET | Source: NEOVACS

Neovacs announces the patent filing in Europe and in the United States for its new therapeutic vaccine candidate Kinoid IL-4/IL-13 for the treatment of allergies

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS...
November 07, 2018 11:45 ET | Source: NEOVACS

Néovacs : preuve de concept in vivo de son nouveau vaccin thérapeutique dans le traitement de l'asthme

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} COMMUNIQUE DE PRESSE · COMMUNIQUE DE...
November 07, 2018 11:45 ET | Source: NEOVACS

Neovacs announces in vivo Proof of Concept success for its IL-4 / IL-13 Kinoid a new Therapeutic Vaccine to treat Mite-induced Asthma

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE · PRESS RELEASE · PRESS...
October 30, 2018 12:50 ET | Source: NEOVACS

NEOVACS : RÉSULTATS SEMESTRIELS 2018

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE...
October 30, 2018 12:50 ET | Source: NEOVACS

NEOVACS : HALF-YEAR 2018 FINANCIAL RESULTS

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE · PRESS RELEASE · PRESS...
October 11, 2018 01:00 ET | Source: NEOVACS

NÉOVACS ANNONCE LA POURSUITE DU DÉVELOPPEMENT DE L'IFNalpha KINOIDE EN CORÉE DU SUD, AVEC SON PARTENAIRE CHONG KUN DANG (CKD) PHARMACEUTICAL

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE · PRESS RELEASE · PRESS...
October 11, 2018 01:00 ET | Source: NEOVACS

NEOVACS ANNOUNCES THE CONTINUATION OF THE DEVELOPMENT OF ITS IFNalpha KINOID IN SOUTH KOREA WITH ITS PARTNER CHONG KUN DANG (CKD) PHARMACEUTICALS

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE · PRESS RELEASE · PRESS...
September 11, 2018 01:00 ET | Source: NEOVACS

NÉOVACS ANNONCE LA LEVÉE DE L'OPTION DE LICENCE SIGNÉE AVEC BIOSENSE GLOBAL POUR LE DÉVELOPPEMENT EN CHINE DE L'IFNalpha KINOIDE DANS LE LUPUS

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE...
September 11, 2018 01:00 ET | Source: NEOVACS

NEOVACS ANNOUNCES THAT ITS PARTNER BIOSENSE GLOBAL HAS EXERCISED ITS OPTION TO ACQUIRE THE EXCLUSIVE LICENCE FOR IFNalpha KINOID TO TREAT LUPUS IN CHINA

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE · PRESS RELEASE · PRESS...
July 03, 2018 01:00 ET | Source: NEOVACS

NEOVACS ANNOUNCES THE RESULTS OF ITS PHASE IIB STUDY FOR IFNalpha KINOID IN THE TREATMENT OF LUPUS

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE · PRESS RELEASE · PRESS...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right